The HMOX1 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population of HeLa cells in which the HMOX1 gene has been disrupted. This heterogeneous mixture provides a loss-of-function model without clonal selection, enabling studies on heme oxygenase-1 function in a diverse cell background. The polyclonal format mirrors natural population variability, making it suitable for assays where clonal uniformity is not required.
HeLa cells, derived from a cervical adenocarcinoma of Henrietta Lacks, are immortal epithelial cells widely used in cancer research, virology, and signal transduction. Their robust proliferation, ease of transfection, and extensive characterization establish them as a standard in vitro model. The HeLa background retains active oxidative stress responses and inflammatory signaling, providing a relevant context for investigating HMOX1-mediated cytoprotection in a cancer setting.
The HMOX1 gene encodes heme oxygenase-1 (HO-1), which degrades pro-oxidant heme into biliverdin, carbon monoxide (CO), and free iron, with NADPH-cytochrome P450 reductase (POR) as a cofactor. Biliverdin is then reduced to bilirubin by biliverdin reductase. HO-1 expression is transcriptionally induced by NFE2L2 (Nrf2) under oxidative stress and repressed by BACH1; additional inducers include heme, heavy metals, and cytokines. The products bilirubin and CO exert antioxidant and anti-inflammatory effects, while liberated iron is stored by ferritin, positioning HMOX1 as a central cytoprotective hub.
Disrupting HMOX1 in HeLa cells ablates a key adaptive response to heme-induced oxidative injury, sensitizing them to stress. Given that cervical adenocarcinoma cells encounter variable pro-oxidant conditions, this model allows exploration of how HO-1 loss impacts cell survival, inflammatory cytokine output, and resistance to chemotherapeutics. The polyclonal knockout system reveals a range of functional consequences, facilitating dose-response analyses of oxidative stressors and dissection of compensatory pathways.
This knockout cell population supports diverse assays, including western blotting and RT-qPCR for HO-1 confirmation, heme oxygenase activity assays via bilirubin measurement, ROS detection, and CO monitoring. Nrf2 nuclear translocation studies can assess pathway activation in the absence of functional HO-1. The model is applicable to oxidative stress research, inflammation studies, and cancer biology, particularly for evaluating cytoprotection mechanisms. For additional information, please contact Ascent Research.
